Micronuclei have been used extensively in studies as an easily evaluated indicator of DNA damage but little is known about their association with other types of damage such as nucleoplasmic bridges and nuclear buds. Here, radiation-induced clastogenic events were evaluated via the cytokinesis-block micronucleus assay in two normal human lymphoblastoid cell lines exposed to neutrons or γ-radiation. DNA damage induced by the chemical agents mitomycin C and phleomycin was also evaluated in two normal and two mitochondrial mutant human lymphoblastoid cell lines. In addition to micronuclei, nucleoplasmic bridges and nuclear buds were enumerated by recording the coincident presence of these end points within individual cells, and the associations among these three end points were evaluated for all treatment conditions. The common odds ratios for micronuclei and nucleoplasmic bridges were found to be significantly larger than unity, indicating that the presence of one or more micronuclei in a cell imposes a significant risk of having one or more nucleoplasmic bridges in that same cell, and vice versa. The strength of this association did not change significantly with radiation dose or concentration of the chemical clastogens. Common odds ratios for association between micronuclei and buds, and between bridges and buds were also found to be significantly higher than unity. However, associations between micronuclei and buds could not be calculated for some treatments due to heterogeneity in the odds ratios and hence may depend on chemical clastogen concentration or radiation dose. This study provides evidence of how paired analyses among genetic end points in the cytokinesis-block micronucleus assay can provide information concerning abnormalities of cell division and possibly about structural chromosomal rearrangements induced by clastogens.
Introduction
Cytogenetic analyses have been used to answer many questions concerning the effects of ionising radiation and potentially clastogenic chemicals in a wide variety of organisms. One of the best-validated methods used for measuring genetic damage in human lymphocytes is the cytokinesis-block micronucleus (CBMN) assay (1) . This assay involves the application of cytochalasin B, an inhibitor of actin polymerisation, to block cytokinesis in mitotic cells. Cells undergoing a single round of mitosis thus become binucleated and are easily distinguished from undivided cells. The CBMN assay is a multi-end point method that can be used to measure different biomarkers of DNA damage. The three different end points that can be analysed simultaneously in this assay are micronuclei, nucleoplasmic bridges and nuclear buds.
Until recently, most studies involving the CBMN assay have considered only micronucleus frequencies and have not evaluated bridges or buds. Micronucleus frequencies are not always simple to interpret because micronuclei may originate by many mechanisms. The action of clastogens gives rise to micronuclei that contain mainly acentric chromosome or chromatid fragments, and these can occur through DNA double-strand breaks (DSBs), or single-strand breaks that are converted into DSBs after DNA replication, or inhibition of DNA synthesis (2) . Micronuclei may also result from lagging whole chromosomes in mitosis due to spindle attachment errors, defects in centromeres and/or kinetochores or abnormal cell cycle check points (2) . Furthermore, micronuclei may be generated by elimination of double minutes by nuclear budding or lagging of double minutes in mitosis (3) . The fragmentation of nucleoplasmic bridges has also been observed to result in the formation of micronuclei (4) . Several modifications that have been made to the assay enable determination of the origins of the induced micronuclei; for example the effects of aneugenic or clastogenic agents can be identified using centromere-specific DNA probes or anti-kinetochore antibodies (5) (6) (7) .
Nucleoplasmic bridges are another indicator of DNA damage and are easily observable alongside micronuclei in the CBMN assay, requiring no additional sample preparation. Bridges originate from dicentric chromosomes that are formed through misrepair of DNA breaks and telomere fusion events (8, 9) . Due to these highly specific origins, scoring of bridges may aid in the interpretation of micronucleus data or provide additional information that is not available through the scoring of micronuclei alone. Previous work has also shown that both micronuclei and bridge induction occur in response to ionising radiation and reactive oxygen species and that these increases are highly correlated (10) . In addition, high correlations between these three genetic end points have been shown in response to folic acid deficiency (11, 12) .
Nuclear buds may also be observed with the CBMN assay. Buds have been shown to form by the elimination of amplified extrachromosomal DNA during interphase as an intermediate step in the formation of double minute-type micronuclei (3, 13) , and also occur from the remnants of broken nucleoplasmic bridges (14) . A correlated increase in micronuclei and buds has been demonstrated in cells treated with mitomycin C or Colcemid® (15) .
Many improvements in the CBMN assay have been made since it was first described (16) . Although studies evaluating the effects of many DNA damaging agents including ionising radiation and chemicals such as mitomycin C (17) and phleomycin (18) have been performed using this assay, there are no published data describing the statistical associations among micronuclei, bridges and buds within each cell. These three end points are important because of the different mechanisms by which each arises. This might yield insights into the different kinds of damage to cells. In the current study, cells treated with γ-radiation, neutron radiation, mitomycin C or phleomycin were analysed. Here, we report that the presence of any one of these three genetic end points in a given cell is significantly associated with an increased probability for the presence of the remaining two outcomes.
Materials and methods

Cell lines
Two normal and two mitochondrial mutant human lymphoblastoid cell lines were obtained from the Coriell Cell Repository. The two normal human lymphoblastoid cell lines used were GM15510 and GM15036. The Leigh syndrome cell line GM13740 carries a mutation of MTATP6 with a mtDNA 8993T>G substitution, while the Leber Optic Atrophy cell line GM10742 carries a mutation of MTND4 with a mtDNA 11778G>A substitution. These mutations were previously confirmed by DNA sequencing work carried out by our laboratory (19) . These mutant cell lines were chosen because they have previously shown differences in their responses to ionising radiation and chemicals compared with the normal lymphoblastoid cell lines (20) .
Cell culture techniques
Cells were cultured in RPMI-1640 medium (Thermo Scientific) supplemented with 15% fetal bovine serum (Atlanta Biological), 2 mM l-glutamine (Gibco), penicillin-streptomycin (100 U/ml penicillin, 100 µg/ml streptomycin) (Gibco) and 2.5 µg/ml amphotericin B (Thermo Scientific) in T25 or T75 CellStar vented suspension culture flasks (Greiner Bio-one) at volumes of not more than 20 ml for T25 flasks and not more than 60 ml for T75 flasks. Cell culture flasks were kept in a fully humidified incubator at a temperature of 37°C and CO 2 concentration of 5%. Cells were seeded at 3 × 10 5 cells/ml and passaged when the concentration reached ~1 × 10 6 cells/ml (3-6 days from time of previous passage depending on the cell line). Cells were fed at intervals of 3 days after passage by careful removal of approximately half of the culture medium in flasks without disturbing sedimented cells and addition of the same volume of fresh cell culture medium. All cell culture medium were pre-warmed to 37°C before use.
Experimental design for mitomycin C and phleomycin exposures
Cells were seeded at 2.5 × 10 5 cells/ml in 10 ml of culture medium in T25 nonvented flasks (Greiner Bio-one) and incubated overnight with loosened caps. To determine damage induced by mitomycin C or phleomycin, cells were exposed to 0, 1 or 3 µg/ml of mitomycin C (CAS# 50-07-7, Santa Cruz Biotechnology) or 0, 50 or 100 µg/ml of phleomycin (CAS# 11006-33-0, InvivoGen) for 1 h. Immediately following that, cells were washed twice with 10 ml RPMI-1640, then once with 10 ml cell culture medium. Each wash was carried out by centrifugation of cell cultures at 134 × g for 5 min, aspiration of the supernatant and resuspension of the cell pellet in the wash medium by gentle agitation with a transfer pipette. Cells were then resuspended in 10 ml cell culture medium and returned to the incubator for 4 h.
Experimental design for γ-radiation and neutron radiation
Cells were seeded at 3.0 × 10 5 cells/ml in 10 ml of culture medium in T25 nonvented flasks (Greiner Bio-one) and incubated overnight with loosened caps. All irradiations were performed in the Gershenson Radiation Oncology Center, Wayne State University, Detroit, MI. For neutron exposures, the cells were cultured in T25 flasks but immediately prior to irradiation the cells were transferred to polypropylene Falcon tubes (Evergreen Scientific, Los Angeles, CA, USA). A cyclotron was used to generate d(48.5)-Be neutrons with the dose rate of 0.3 Gy/min at doses of 0 (control), 0.5, 1, 1.5, 2, 3 and 4 Gy. Following exposure the cells were returned immediately to the laboratory, transferred to new T25 culture flasks and incubated as described. For the neutron radiations given with this clinical machine, 6% of the total dose (neutrons plus gamma rays) is due to contamination from γ-radiation produced mostly by the absorption of neutrons in the beam collimator, as is always the case with particle irradiators. For evaluation of damage induced by low-dose γ-radiation only, cultures of GM15510 and GM15036 were acutely irradiated with a cobalt-60 source using a Theratron radiotherapy unit (Atomic Energy of Canada) with the dose rate of 0.25 Gy/min. The doses used were equivalent to the 6% contamination of γ-radiation in the neutron beam exposures, i.e. 0 (control), 0.03, 0.06, 0.09, 0.12, 0.18 and 0.24 Gy. To evaluate effects of higher doses of γ-radiation, cells were also irradiated in a separate experiment with γ-radiation doses of 0 (control), 0.5, 1, 2, 3 and 4 Gy. For γ-radiation, cells were cultured in T25 flasks and irradiated, after which they were brought back to the laboratory and returned to the incubator for 4 h.
Cytokinesis-block micronucleus assay
Following 4 h of incubation, 6 µg/ml of cytochalasin B (Sigma) was added to each culture. A stock of 600 µg/ml cytochalasin B in dimethyl sulphoxide was used for a final dimethyl sulphoxide concentration of 1% in treated cultures. Twenty-eight hours after addition of cytochalasin B, cells were harvested by centrifugation onto ethanol-cleaned glass slides using a StatSpin Cytofuge 2 cytocentrifuge. After drying briefly in air, the cells were fixed in 100% methanol for 15 min.
Giemsa staining and slide preparation
Fixed slides were immersed in 5% Giemsa, prepared by diluting 2.5 ml Giemsa stain (Acros Organics) in 47.5 ml dH 2 O, for 20 min. Slides were then rinsed briefly in dH 2 O and air-dried. For long-term storage, slides were mounted with a drop of Permount (Fisher Scientific) and 22 × 22 mm 2 or 25 × 25 mm 2 glass coverslips.
Data collection
All slides were read by trained scorers on Nikon Eclipse E200 light microscopes at ×1000 magnification and were coded prior to scoring to prevent observer bias. For chemical-treated slides, at least 1000 binucleated cells were scored for micronuclei, nucleoplasmic bridges and nuclear buds for each treatment condition by a single person. For 0.5-4 Gy γ-irradiated slides, ~500 cells were scored by each of two trained people for a total of ~1000 binucleated cells per treatment group.
For cell lines treated with neutron radiation or low-dose γ-radiation (0.03-0.24 Gy), 1200-18 000 binucleated cells were scored for each treatment condition. A large number of cells had to be scored for low doses of γ-radiation because these doses induce low levels of damage for each of the three biomarkers. The scoring was performed by trained observers and was shared between two to four scorers such that for each dose, each scorer evaluated approximately the same number of cells.
To determine whether there were enough binucleated cells for each treatment condition, the mean number of nuclei per cell was determined by counting 300-400 cells. These data indicated that the numbers of binucleated cells were high enough to enumerate micronuclei, bridges and buds for every treatment condition except for cells irradiated with 3 or 4 Gy neutrons. For low doses of photons, determination of the mean number of nuclei was not necessary because doses higher than these had enough binucleated cells to enumerate all three end points.
Cell scoring criteria
Cells were scored essentially according to established criteria (21, 22) , with refinements as illustrated in Figure 1 . For the neutron experiments, all binucleated cells with non-overlapping nuclei were included for evaluation; this includes cells where the two nuclei were touching each other, as shown in Figure 1b and 1c. This approach is referred to here as the 'relaxed' criteria. For the chemical clastogen and γ-radiation experiments, the nuclei were required to be well separated and not in contact with each other at any point, as shown in Figure 1d . This approach is referred to here as the 'stringent' criteria. For all experiments, the cells were also required to have fully intact cytoplasm with boundaries that were clearly distinct from adjacent cells. All cells were evaluated simultaneously for three different end points: micronuclei, bridges and buds; the coincident presence of these end points within individual cells was recorded. Entities were considered to be micronuclei if they had similar colour and texture to the main nuclei, had a diameter of less than one-third that of the main nuclei, were round or oval with a clear and well-defined boundary and were located fully within the cytoplasm. Nucleoplasmic bridges were considered to be fully continuous extensions of nucleoplasm that spanned from one nucleus to the other, with similar staining characteristics to nuclei. Nuclear buds were required to appear similar to micronuclei and had to be visibly attached to a single main nucleus via a stalk that was narrower than the widest point across the bud.
Statistical analyses
The odds ratios for the presence of micronuclei, bridges and buds in cells were calculated for each chemical clastogen concentration or radiation dose for each cell line within each treatment condition. Homogeneity of the odds ratios within the treatment sets was evaluated by Woolf's test of heterogeneity (23) . If no significant heterogeneity of the odds ratios was found, the hypotheses that the common odds ratios for each cell line within each treatment group were >1 was evaluated by the Mantel-Haenszel chi-square test with continuity correction (24) 
Results and discussion
All treatment of cell lines with mitomycin C, phleomycin, γ-radiation or neutron radiation induced a chemical clastogen concentration-or radiation dose-dependent increase in micronuclei, bridges and buds (Figures 2 and 3 ). All cell lines showed decreases in the average number of nuclei per cell with increasing chemical concentration or radiation dose, consistent with increasing cytotoxicity of the treatments with dose or concentration (Tables I-III) . The dose responses shown by these data are in general agreement with prior work from our laboratory with both radiation and chemicals (18, 25) .
Two different approaches to scoring binucleated cells were used in this study; these differed with respect to the physical distance that was required to exist between the two nuclei in each cell being considered for analysis. The 'stringent' scoring criteria required the nuclei to have substantial distance between them, while the 'relaxed' scoring criteria allowed the nuclei to be touching, as shown in Figure 1 . Only the scoring itself differed between each set of criteria; slides were otherwise prepared with identical materials and procedures, and criteria for determining whether an entity within the cytoplasm was to be considered a micronucleus, bridge or bud were unchanged. To evaluate the effects of increasing the stringency of scoring criteria on counts of micronuclei, bridges and buds, a single observer scored 11 slides of γ-irradiated (0, 0.5, 1, 2, 3 and 4 Gy) normal human lymphoblastoid cells. Each of these slides was evaluated first with the relaxed criteria and subsequently with the stringent criteria. A direct comparison of the results produced by these two scoring methods showed that while micronuclei and bud frequencies did not differ substantially between the two criteria, the frequency of bridges was 2-fold higher when evaluated with the stringent criteria compared with the relaxed criteria (data not shown). This higher value may better represent the true frequency of bridges in these samples. However, it should be noted that use of the stringent criteria also resulted in nearly a 70% reduction in the number of scorable cells obtained from each slide. This comparison of scoring methods suggests that the use of stringent criteria aids significantly in the observation of bridges compared with the relaxed criteria, with the caveat of an almost 3-fold reduction in the number of scorable cells. Two strategies that may be used in the future to help overcome this large loss of scorable cells are to increase the number of cells per slide and to increase the proportion of scorable cells. The first may be achieved by using a higher concentration of cells when spinning them onto slides. Too few binucleated cells to score for micronuclei, bridges and buds. Missing values at some doses indicate that the odds ratio could not be calculated due to a lack of cells containing one or both of the two end points being evaluated. Common odds ratio could not estimated due to significant heterogeneity (P < 0.05) in the odds ratios.
c Common odds ratio not significantly >1 (P > 0.05).
The second may be carried out by increasing the centrifugation speed and perhaps by hypotonic pre-treatment of cells. Cells treated with either mitomycin C, phleomycin, γ-radiation or neutron radiation were then evaluated using either the stringent or the relaxed criteria, with cell counts ranging from 1000 to 18 000 binucleated cells depending on the treatment condition, with lower doses generally having more cells counted. Three different cytogenetic end points, i.e. micronuclei, nucleoplasmic bridges and buds, were evaluated simultaneously in each cell, regardless of the scoring criterion employed, and the number of cells with at least one of these end points present ranged from a low of 45 in control treatments to a high of 1078 in clastogen-treated cultures. For each treatment condition, all the common odds ratios for the presence of micronuclei and nucleoplasmic bridges were found to be significantly higher than 1.00 (Table  IV) , indicating that the presence of bridges is a significant risk factor for the presence of micronuclei within a cell, and vice versa. Additionally, within each cell line, the odds ratios for the presence of micronuclei and bridges for each treatment condition do not differ significantly from each other ( Figures  4a and b and 5a-c) , indicating that the effects of the presence of bridges on the presence of micronuclei (and vice versa) are fairly constant despite changes in radiation doses or chemical concentrations. In addition, between the two normal human lymphoblastoid cell lines, the common odds ratios for micronuclei and bridges for both types of radiation and both chemicals are similar. This suggests that regardless of the genotype, the mechanism for the formation of micronuclei and bridges remains the same in different cell lines and for different types of clastogens. These relationships were consistent across both the stringent and the relaxed scoring criteria despite the differences in the frequencies of bridges as already shown.
From a mechanistic standpoint, these observations may be explained by asymmetrical chromosome exchanges that result from the misrepair of DSBs, where each such event leads to rearrangements that generate an acentric chromosome fragment and a dicentric chromosome. Many of these dicentrics and fragments would emerge in the next metaphase as bridges and fragments, respectively, and the fragments could also appear in the next interphase as micronuclei. The breakagefusion-bridge cycle, a mechanism of chromosome instability involving repeated cycles of fusion between chromosomes or chromatids and their subsequent breakage during cell division as centromeres separate (9, 26) , has been proposed to explain the observation that the presence of micronuclei, bridges and buds is highly correlated in folic acid-deficient cells (11, 12) . The same is not likely in this experiment, as cells are treated with cytochalasin B 4 h following clastogenic treatment, thus preventing cells from undergoing more than one cell division after the initial damage. Therefore, mechanisms other than the breakage-fusion-bridge cycle must be significant contributors in our observation of correlated increases in micronuclei, bridges and buds.
Our results suggest that not only do asymmetrical chromosome exchanges account for a fixed, observable proportion of the micronuclei and bridges generated by treatment with clastogens but also that the CBMN assay is capable of detecting such events. The frequency of micronuclei may provide an estimate of the number of acentric fragments produced in response to a treatment. Similarly, the frequency of nucleoplasmic bridges may be a reliable indicator of the number of dicentrics present (10) . By producing a calibration curve comparing the number of dicentric and acentric chromosomes from Giemsa-stained metaphase spreads with the micronuclei and bridge frequencies induced in CBMN assay, it may be possible to predict the results of one assay without performing the other. Cells undergoing apoptosis and necrosis were not recorded in this study; these biomarkers may affect the relationships between micronuclei, buds and bridges. More studies are required to investigate this further.
Positive associations, as evaluated by odds ratios, also occurred for the presence of micronuclei and nuclear buds (Figures 4c and d and 5d-f) , and for the presence of nucleoplasmic bridges and nuclear buds (Figures 4e and f and 5g-i) within each cell in cell lines treated with mitomycin C, phleomycin, γ-radiation or neutron radiation. While it is known that certain types of micronuclei arise by nuclear budding, and that some buds arise from the breaking of bridges, it is unclear how these simple relationships would lead to an increased concurrent presence of buds with bridges or micronuclei in each cell. An alternative explanation is that certain cells within the cell population have increased susceptibility to DNA damage; variability in radiosensitivity of individual cells based on their phase in the cell cycle is known to occur (27) . Thus, the positive associations between the different end points in individual cells may be due (at least in part) to an increased frequency of radiation or chemical damage within this certain subset of cells (27) .
Unlike the odds ratios between micronuclei and bridges, and between bridges and buds, the odds ratios for the presence of micronuclei and buds were found to be heterogeneous for 4 of the 14 treatment sets examined. This suggests that the association between micronuclei and buds is not static among various treatment conditions but may be dependent on chemical concentration or radiation dose. However, it should also be cautioned that the visual means used to identify buds in the CBMN assay may allow misidentification of a small number of micronuclei as buds, as micronuclei in contact with cell nuclei may not easily be determined to be separate through visual means alone. Thus, the possibility remains that any statistical association involving buds could be due to micronuclei that were incorrectly identified as buds.
In conclusion, in cells treated with mitomycin C, phleomycin, γ-radiation and neutron radiation, the occurrence of micronuclei, bridges and buds within individual cells are positively associated with each other. This suggests the existence of a common mechanism of generation for these end points by chromosomal damage and structural chromosome rearrangements. Differences in radiosensitivity of individual cells within the cell population according to their position in the cell cycle at the time of exposure may also be important. Altering the scoring criteria of the CBMN assay such that only binucleated cells with well-separated nuclei are counted, as opposed to counting all binucleated cells with non-overlapping nuclei, significantly increases the frequency of bridges observed. Regardless of the scoring method used, statistically significant associations among micronuclei, bridges and buds have been demonstrated in the work described here.
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